Emerging Treatment for Anemia of CKD: HIF-PH Inhibitors - a podcast by ReachMD

CME credits: 0.25

Valid until: 15-12-2023

Claim your CME credit at https://reachmd.com/programs/cme/emerging-treatment-for-anemia-of-ckd-hif-ph-inhibitors/16089/

In this activity, Dr. Jay Wish, Chief Medical Officer for Outpatient Dialysis in the Division of Nephrology at Indiana University Health, discusses emerging treatment for Anemia of chronic kidney disease (CKD), specifically with hypoxia-inducible factor–prolyl hydroxylase domain (HIF-PH) inhibitors.

=

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD